-5%

 17,500.00

Content Details
Information on this page was last modified on : 2022/11/29 4:59:51 PM

Trulicity Injection 1.5 mg Pre filled Pen^

(1 customer review)

Trulicity Injection contains Dulaglutide | belongs to GLP- 1 agonist

How it works

Trulicity Injection 1.5 mg Pre filled Pen^ works by helping the pancreas to release the right amount of insulin when blood sugar levels are high.

Side effects

Major & minor side effects for Trulicity Injection 1.5 mg Pre filled Pen^

  • Diarrhea
  • Decreased appetite
  • Lack or loss of strength
  • Stomach discomfort
  • Nausea
  • Vomiting
  • Abdominal pain
  • Fatigue

Uses of Trulicity Injection 1.5 mg Pre filled Pen^

What is it prescribed for?

  • Type II Diabetes Mellitus

    This medicine is used along with an appropriate diet and exercise regimen to reduce blood glucose levels in patients with type 2 diabetes. It is generally used when adequate control of blood sugar levels is not achieved after therapy with other oral antidiabetic medicines.

Concerns

Frequently asked questions

  • Onset of action

    The amount of time required for this medicine to show its action is not clinically established.

  • Duration of Effect

    The amount of time for which this medicine remains active in the body is not clinically established.

  • Safe with Alchohol?

    Avoid or limit the uptake of alcohol while receiving this medicine due to the increased risk of altered blood glucose levels. Special precaution is advised if your diabetes is not well controlled or if you are suffering from high triglycerides levels, neuropathy (nerve damage), or pancreatitis.

  • Is it habit forming?

    No habit-forming tendencies were reported.

  • Usage in pregnancy?

    This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.

  • Usage while breast-feeding?

    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.

When not to use?

  • Allergy

    This medicine is not recommended for use in patients with a known allergy to Trulicity Injection 1.5 mg Pre filled Pen^ or any other inactive ingredients present along with it.

  • Medullary thyroid carcinoma

    This medicine is not recommended for use in patients with a personal or family history of medullary thyroid carcinoma due to the increased risk of worsening of the patient’s condition.

  • Multiple endocrine neoplasia type 2

    This medicine is not recommended for use in patients with a known history of multiple endocrine neoplasia type 2 since the safety and efficacy of this medicine have not been established for such patients.

Warnings

Warnings for special population
  • Pregnancy

    This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.

  • Breast-feeding

    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.

General Warnings
  • Angioedema

    This medicine may cause anaphylaxis and other hypersensitivity reactions, including angioedema, in some patients. Appropriate corrective measures, dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

  • Kidney disease

    This medicine should be used with caution in patients with kidney diseases due to the increased risk of severe adverse effects. Regular monitoring of kidney function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

  • Liver disease

    This medicine should be used with caution in patients with liver diseases due to the increased risk of adverse effects. Regular monitoring of liver function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

  • Use in children

    This medicine is not recommended for use in children below 18 years of age since the safety and efficacy of use are not clinically established.

  • Gastroparesis

    This medicine is not recommended for use in patients with gastroparesis due to the increased risk of serious adverse effects. An alternative treatment option may be necessary in some cases based on the clinical condition.

  • Concomitant use of Insulin or insulin secretagogues

    Concomitant dosing of insulin or insulin secretagogues should be evaluated due to the risk of hypoglycemia (low blood sugar levels). Risk of severe fall in blood sugar levels should be considered during dosing.

  • Pancreatitis

    This medicine should be used with caution in patients with pre-existing pancreatitis since it may worsen the patient's condition. Use should be discontinued immediately if symptoms of pancreatitis worsen.

Dosage

  • Missed Dose

    Administer the missed dose as soon as you remember. If it is almost time for the next dose, skip the missed dose and continue with the regular dosing schedule. Do not double the dose to make up for the missed one.

  • Overdose

    Seek emergency medical treatment or contact the doctor in case of an overdose.

Interactions

Interaction with Medicines
  • Atazanavir moderate
  • Chlorothiazide moderate
  • Ciprofloxacin moderate
  • Acetazolamide moderate
  • Bexarotene severe
  • Clozapine moderate
  • Gatifloxacin severe
Disease interactions
  • severe

    This medicine should be used with caution and monitoring in patients with pre-existing pancreatitis. Treatment with this medicine should be discontinued immediately if symptoms worsen. An alternative treatment option may be necessary in such cases based on the clinical condition.

  • moderate

    This medicine should be used with caution in patients with kidney diseases due to the increased risk of severe adverse effects. Regular monitoring of kidney function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

  • severe

    This medicine is not recommended for use in patients with a personal or family history of medullary thyroid carcinoma and in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN2) due to the increased risk of worsening of the patient’s condition. An alternative treatment option should be considered in such cases based on the clinical condition.

General Instructions

Administer This medicine with or without food. Do not administer in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.

Other details

  • Can be taken with or without food, as advised by your doctor
  • To be taken as instructed by doctor
  • Does not cause sleepiness

References

Additional Information:

How to use Trulicity Injection 1.5 mg Pre filled Pen^

Inject subcutaneously in the abdomen, thigh, or upper arm.

what are the adverse effects of Trulicity Injection 1.5 mg Pre filled Pen^?

Nausea, diarrhoea, vomiting, abdominal pain, decreased appetite.

What happens if I miss a dose of Trulicity Injection 1.5 mg Pre filled Pen^?

Adults: Once weekly at any time of day. Initial dose: 0.75 mg subcutaneously once weekly. Dose can be increased to 1.5 mg once weekly for additional glycaemic control.
Children: Not recommended.

One of the following licensed pharmacy from the nearest location will deliver Trulicity Injection 1.5 mg Pre filled Pen^. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

Want to share this information?
Facebook
Twitter
LinkedIn
Something doesn't feel right ?

Questions and Answers

There are no questions yet. Be the first to ask a question about this product.

Only registered users are eligible to enter questions

1 review for Trulicity Injection 1.5 mg Pre filled Pen^

  1. raees arshad butt

    raees arshad butt submitted 1 stars.

Add a review
Shopping Cart